IL132085A0 - Compounds - Google Patents

Compounds

Info

Publication number
IL132085A0
IL132085A0 IL13208598A IL13208598A IL132085A0 IL 132085 A0 IL132085 A0 IL 132085A0 IL 13208598 A IL13208598 A IL 13208598A IL 13208598 A IL13208598 A IL 13208598A IL 132085 A0 IL132085 A0 IL 132085A0
Authority
IL
Israel
Prior art keywords
compounds
Prior art date
Application number
IL13208598A
Other languages
English (en)
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of IL132085A0 publication Critical patent/IL132085A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL13208598A 1997-04-09 1998-04-07 Compounds IL132085A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9701304A SE9701304D0 (sv) 1997-04-09 1997-04-09 Compounds
PCT/SE1998/000641 WO1998045294A1 (en) 1997-04-09 1998-04-07 Compounds

Publications (1)

Publication Number Publication Date
IL132085A0 true IL132085A0 (en) 2001-03-19

Family

ID=20406499

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13208598A IL132085A0 (en) 1997-04-09 1998-04-07 Compounds

Country Status (21)

Country Link
US (1) US6303613B1 (cs)
EP (1) EP0973772A1 (cs)
JP (1) JP2001519805A (cs)
KR (1) KR20010006143A (cs)
CN (1) CN1259131A (cs)
AU (1) AU7091098A (cs)
BR (1) BR9807950A (cs)
CA (1) CA2285388A1 (cs)
CZ (1) CZ355199A3 (cs)
EE (1) EE9900448A (cs)
HU (1) HUP0001865A2 (cs)
ID (1) ID23861A (cs)
IL (1) IL132085A0 (cs)
IS (1) IS5208A (cs)
NO (1) NO994900L (cs)
NZ (1) NZ338006A (cs)
PL (1) PL336141A1 (cs)
SE (1) SE9701304D0 (cs)
SK (1) SK128999A3 (cs)
TR (1) TR199902495T2 (cs)
WO (1) WO1998045294A1 (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
SE9901530D0 (sv) * 1999-04-28 1999-04-28 Astra Pharma Prod Novel compounds
ATE283048T1 (de) 1999-12-08 2004-12-15 Pharmacia Corp Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt
EP1299122A2 (en) * 2000-07-13 2003-04-09 Pharmacia Corporation Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
EP1303265B1 (en) 2000-07-20 2007-07-11 Lauras AS Use of cox-2 inhibitors as immunostimulants in the treatment of hiv or aids
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
CA2482510A1 (en) * 2002-04-18 2003-10-30 Pharmacia Corporation Monotherapy for the treatment of parkinson`s disease with cyclooxygenase-2 (cox 2) inhibitor(s)
EP1494664A2 (en) * 2002-04-18 2005-01-12 Pharmacia Corporation Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
AU2003260033A1 (en) * 2002-08-29 2004-03-19 Schering Aktiengesellschaft Methods of treating acute respiratory distress syndrome
EP1558081A4 (en) * 2003-01-13 2006-06-14 Dynogen Pharmaceuticals Inc METHOD FOR THE TREATMENT OF FUNCTIONAL ENDURANCE DISEASES
WO2004101523A1 (en) * 2003-05-17 2004-11-25 Korea Research Institute Of Bioscience And Biotechnology Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
DE102005024012A1 (de) * 2005-05-20 2006-11-23 Grünenthal GmbH Verwendung von 2,5-disubstituierten Thiazol-4-on-Derivaten in Arzneimitteln
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
AU2006286601B2 (en) * 2005-09-01 2012-07-05 F. Hoffmann-La Roche Ag Diaminopyrimidines as P2X3 and P2X2/3 modulators
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
MX2010013477A (es) 2008-06-18 2010-12-21 Astrazeneca Ab Derivados de benzoxazinona que actuan como agonistas de receptores adrenergicos beta2 para el tratamiento de trastornos respiratorios.
US20240165148A1 (en) 2021-03-15 2024-05-23 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3403152A (en) * 1967-03-20 1968-09-24 Ciba Geigy Corp 1-aryl-4-imino-1, 2, 3, 4-tetrahydroquinazolines
US3483205A (en) * 1967-12-22 1969-12-09 Ciba Geigy Corp Bicyclic tetrahydropyrimidines
SE9703693D0 (sv) * 1997-10-10 1997-10-10 Astra Pharma Prod Novel combination

Also Published As

Publication number Publication date
AU7091098A (en) 1998-10-30
CA2285388A1 (en) 1998-10-15
HUP0001865A2 (hu) 2001-01-29
WO1998045294A1 (en) 1998-10-15
IS5208A (is) 1999-10-05
PL336141A1 (en) 2000-06-05
NZ338006A (en) 2001-04-27
KR20010006143A (ko) 2001-01-26
TR199902495T2 (xx) 2000-07-21
US6303613B1 (en) 2001-10-16
BR9807950A (pt) 2000-03-08
EP0973772A1 (en) 2000-01-26
NO994900L (no) 1999-11-19
MX9909188A (en) 2001-07-01
ID23861A (id) 2000-05-25
CZ355199A3 (cs) 2000-03-15
JP2001519805A (ja) 2001-10-23
SK128999A3 (en) 2000-05-16
NO994900D0 (no) 1999-10-08
CN1259131A (zh) 2000-07-05
SE9701304D0 (sv) 1997-04-09
EE9900448A (et) 2000-04-17

Similar Documents

Publication Publication Date Title
GB9714102D0 (en) Compounds
GB9715584D0 (en) Compounds
GB9710569D0 (en) Compounds
IL132085A0 (en) Compounds
GB9708694D0 (en) Compounds
GB9708805D0 (en) Compounds
GB9709303D0 (en) Compounds
GB9711492D0 (en) Compounds
GB9704522D0 (en) Compounds
GB9712849D0 (en) Compounds
GB9702978D0 (en) Compounds
GB9704652D0 (en) Compounds
GB9708802D0 (en) Compounds
GB9708071D0 (en) Compounds
GB9708070D0 (en) Compounds
GB9707444D0 (en) Compounds
GB9707443D0 (en) Compounds
GB9706953D0 (en) Compounds
GB9706952D0 (en) Compounds
GB9706110D0 (en) Compounds
GB9705652D0 (en) Compounds
GB9705194D0 (en) Compounds
GB9705189D0 (en) Compounds
GB9705188D0 (en) Compounds
GB9715804D0 (en) Compounds